Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-29 | Dr. Karabelas does not currently serve on the Board. Since December 2001, Dr. Karabelas has been a Partner at Care Capital, LLC ("Care Capital"), a life sciences venture firm with $500M under management. |
| 2018-03-21 | Dr. Argeris (Jerry) N. Karabelas New Hampshire, USA Age 65 Independent 4,000 Common Shares — $61,600 42,132 RSUs (comprised of 16,726 vested RSUs — $257,580 and 25,406 unvested RSUs — $391,252) No Options Total Equity Value at Risk: $319,180, representing 64% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-management Directors and 320% of the Director’s annual retainer. Dr. Karabelas has until June 2021 to achieve the expected minimum equity ownership under the share ownership guidelines. 2017 Meeting Attendance: Board — 8/8; Finance and Transactions Committee — 6/6; Talent and Compensation Committee — 4/4. Director Compensation Table: Dr. Argeris (Jerry) N. Karabelas Fees Earned or Paid in Cash ($): 127,885 Stock Awards ($): 249,995 All Other Compensation ($): — Total ($): 377,880 |
| 2019-03-18 | Dr. Argeris (Jerry) N. Karabelas Age 66 Independent 2018 Meeting Attendance: Board 5/5 Talent and Compensation Committee 5/5 Finance and Transactions Committee- 5/5 Director Compensation Table: Dr. Argeris (Jerry) N. Karabelas Fees Earned or Paid in Cash: 135,622 Stock Awards: 250,000 All Other Compensation: 0 Total: 385,622 |
| 2020-03-16 | Dr. Argeris (Jerry) N. Karabelas Age 67 Independent 2019 Meeting Attendance: Board 6/6, Talent and Compensation Committee 5/5, Science and Technology Committee 4/4. Director Compensation Table: Fees Earned or Paid in Cash $137,500, Stock Awards $250,000, Total $387,500. |
| 2021-03-18 | Dr. Argeris (Jerry) N. Karabelas New Hampshire, USA Age 68 Independent Stock Ownership: 4,000 Common Shares $127,000 77,683 RSUs (comprised of 66,646 vested RSUs $2,116,011, and 11,037 unvested RSUs $350,425) Total Equity Value at Risk: $2,243,011, representing 449% of the Company’s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 2,243% of the annual Board retainer. 2020 Meeting Attendance: Board 9/9 Talent and Compensation Committee 7/7 Science and Technology Committee 6/6 Special Transactions Committee 4/4 |
| 2022-05-02 | Dr. Karabelas has served on the Board since June 2016. ... 2021 Meeting Attendance: Board 8/8, Talent and Compensation Committee 9/9, Science and Technology Committee 5/5, Special Transactions Committee 5/5. |
Data sourced from SEC filings. Last updated: 2026-02-03